NASHVILLE, Tenn.--(BUSINESS WIRE)--Caremark Rx, Inc. (NYSE: CMX) today issued the following statement regarding Express Scripts, Inc. (NASDAQ: ESRX) withdrawal and planned re-filing of its pre-merger notification and report form under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, relating to Express Scripts’ unsolicited bid for Caremark.
